IL1B and infarction: In a focal cerebral ischemia model, sevoflurane preconditioning reduced cerebral infarct size, improved neural function, and reduced apoptosis through anti-inflammation (e.g., by reducing tumour necrosis factor-alpha and interleukin 1-β (IL1-β) levels) [55].